Eton Pharmaceuticals, Inc. (ETON) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGM. Market cap 1.56B USD. 52-week range 14.27 to 66.37 USD. Trailing P/E 136.9. Data as of 2026-10-09.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for ...